Cardiac Rhythm Management Devices | Asia Pacific | 2016 | Market Analysis
The Asia Pacific market for CRM devices will experience robust growth through 2024, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. Uptake of premium-priced devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs will help mitigate the price erosion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for CRM device in Asia Pacific across a 10-year period.